These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 24025552)

  • 1. Human basal cell carcinoma tumor-initiating cells are resistant to etoposide.
    Colmont CS; Ketah AB; Errington RJ; Reed SH; Udey MC; Patel GK
    J Invest Dermatol; 2014 Mar; 134(3):867-870. PubMed ID: 24025552
    [No Abstract]   [Full Text] [Related]  

  • 2. Changes in subcellular distribution of topoisomerase IIalpha correlate with etoposide resistance in multicell spheroids and xenograft tumors.
    Oloumi A; MacPhail SH; Johnston PJ; Banáth JP; Olive PL
    Cancer Res; 2000 Oct; 60(20):5747-53. PubMed ID: 11059769
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cell fusion studies to examine the mechanism for etoposide resistance in Chinese hamster V79 spheroids.
    Luo C; Johnston PJ; MacPhail SH; Banáth JP; Oloumi A; Olive PL
    Exp Cell Res; 1998 Sep; 243(2):282-9. PubMed ID: 9743588
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Paclitaxel for progressive basal cell carcinoma.
    Barceló R; Viteri A; Muñoz A; Gil-Negrete A; Rubio I; López-Vivanco G
    J Am Acad Dermatol; 2006 Feb; 54(2 Suppl):S50-2. PubMed ID: 16427996
    [No Abstract]   [Full Text] [Related]  

  • 5. The clinical pharmacology of etoposide: an update.
    Joel S
    Cancer Treat Rev; 1996 May; 22(3):179-221. PubMed ID: 8841390
    [No Abstract]   [Full Text] [Related]  

  • 6. Companies race to develop first Hedgehog inhibitor cancer drug.
    Dolgin E
    Nat Med; 2011 May; 17(5):523. PubMed ID: 21546955
    [No Abstract]   [Full Text] [Related]  

  • 7. Superficial basal cell carcinoma successfully treated with ingenol mebutate gel 0.05%.
    Cantisani C; Paolino G; Cantoresi F; Faina V; Richetta AG; Calvieri S
    Dermatol Ther; 2014; 27(6):352-4. PubMed ID: 25052730
    [No Abstract]   [Full Text] [Related]  

  • 8. Differential gene and microRNA expression between etoposide resistant and etoposide sensitive MCF7 breast cancer cell lines.
    Moitra K; Im K; Limpert K; Borsa A; Sawitzke J; Robey R; Yuhki N; Savan R; Huang da W; Lempicki RA; Bates S; Dean M
    PLoS One; 2012; 7(9):e45268. PubMed ID: 23028896
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mithramycin inhibits etoposide resistance in glucose-deprived HT-29 human colon carcinoma cells.
    Lee EM; Park HR; Hwang JH; Park DJ; Chang KS; Kim CJ
    J Microbiol Biotechnol; 2007 Nov; 17(11):1856-61. PubMed ID: 18092471
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Expression of ATP binding cassette superfamily (multidrug resistance-1, multidrug resistance-associated protein, human canalicular multispecific organ anion transporter) mRNA in etoposide and m-AMSA resistant cell lines].
    Matsumoto Y; Matsumoto M; Minemura M; Takano H; Nagao S; Iglesias A; Fojo T
    Gan To Kagaku Ryoho; 1997 Oct; 24(13):1941-6. PubMed ID: 9350240
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of the properties of human breast cancer cells: MCF-7 and MCF-7 cells selected for resistance to etoposide.
    Cory AH; Cory JG
    Adv Enzyme Regul; 2001; 41():177-88. PubMed ID: 11384744
    [No Abstract]   [Full Text] [Related]  

  • 12. Vismodegib resistant mutations are not selected in multifocal relapses of locally advanced basal cell carcinoma after vismodegib discontinuation.
    Ighilahriz M; Benfodda M; Sharpe H; Soufir N; Mourah S; Dumaz N; Battistella M; Savina A; Bouquet F; Nikolaev S; Basset-Seguin N
    J Eur Acad Dermatol Venereol; 2019 Nov; 33(11):e422-e424. PubMed ID: 31187903
    [No Abstract]   [Full Text] [Related]  

  • 13. Hypophosphorylation of topoisomerase IIalpha in etoposide (VP-16)-resistant human carcinoma cell lines associated with carboxy-terminal truncation.
    Matsumoto Y; Takano H; Kunishio K; Nagao S; Fojo T
    Jpn J Cancer Res; 2001 Jul; 92(7):799-805. PubMed ID: 11473732
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expression analysis of TOP2A, MSH2 and MLH1 genes in MCF7 cells at different levels of etoposide resistance.
    Kaplan E; Gündüz U
    Biomed Pharmacother; 2012 Feb; 66(1):29-35. PubMed ID: 22285073
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Optimal combination chemotherapy and chemoradiotherapy with etoposide for advanced cervical squamous cancer cells in vitro.
    Tanaka T; Bai T; Yukawa K; Umesaki N
    Oncol Rep; 2006 Apr; 15(4):939-47. PubMed ID: 16525683
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Etoposide-mediated sensitization of squamous cell carcinoma cells to tumor necrosis factor-related apoptosis-inducing ligand (TRAIL)-induced loss in mitochondrial membrane potential.
    Itoh M; Noutomi T; Toyota H; Mizuguchi J
    Oral Oncol; 2003 Apr; 39(3):269-76. PubMed ID: 12618199
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Transfection of a human topoisomerase II alpha gene into etoposide-resistant human breast tumor cells sensitizes the cells to etoposide.
    Asano T; An T; Zwelling LA; Takano H; Fojo AT; Kleinerman ES
    Oncol Res; 1996; 8(3):101-10. PubMed ID: 8823806
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Smoothened mutations underlie Basal cell carcinoma resistance.
    Cancer Discov; 2015 May; 5(5):OF9. PubMed ID: 25813347
    [No Abstract]   [Full Text] [Related]  

  • 19. Drug resistance towards etoposide and cisplatin in human melanoma cells is associated with drug-dependent apoptosis deficiency.
    Helmbach H; Kern MA; Rossmann E; Renz K; Kissel C; Gschwendt B; Schadendorf D
    J Invest Dermatol; 2002 Jun; 118(6):923-32. PubMed ID: 12060385
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Blocking signaling through the Gp130 receptor chain by interleukin-6 and oncostatin M inhibits PC-3 cell growth and sensitizes the tumor cells to etoposide and cisplatin-mediated cytotoxicity.
    Borsellino N; Bonavida B; Ciliberto G; Toniatti C; Travali S; D'Alessandro N
    Cancer; 1999 Jan; 85(1):134-44. PubMed ID: 9921985
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.